Effect of pine bark extract (Pycnogenol®) on symptoms of knee osteoarthritis

Phytotherapy Research

Volumn 22, Issue 8, 2008, Pages 1087-1092

  Cisár, Peter ^a   Jány, Richard ^a   Waczulíkova, Iweta ^c   Sumegová, Katarína ^b   Muchová, Jana ^b   Vojtaššák, Jozef ^a   Ďuraćková, Zdenka ^b   Lisý, Miroslav ^a   Rohdewald, Peter ^d,e  

^a UNIVERSITY HOSPITAL BRATISLAVA   (Slovakia)

^b Faculty of Medicine of Comenius University and University Hospital Bratislava   (Slovakia)

^c Physics and Informatics   (Slovakia)

^d UNIVERSITY OF MÜNSTER   (Germany)

^e Twenteweg 15   (Germany)

Author keywords

Osteoarthritis; Pine bark extract; Pycnogenol ; WOMAC

Indexed keywords

ANALGESIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; PINE BARK EXTRACT; PLACEBO; PLANT EXTRACT; PYCNOGENOL; UNCLASSIFIED DRUG;

ADULT; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BARK; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG TOLERABILITY; DRUG WITHDRAWAL; FEMALE; HUMAN; KNEE OSTEOARTHRITIS; MAJOR CLINICAL STUDY; MALE; MEDICINAL PLANT; PAIN; PINE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; STATISTICAL SIGNIFICANCE; SYMPTOM; TREATMENT DURATION; UNSPECIFIED SIDE EFFECT; VISUAL ANALOG SCALE;

ACTIVITIES OF DAILY LIVING; ADJUVANTS, IMMUNOLOGIC; ADULT; AGED; DOUBLE-BLIND METHOD; FEMALE; FLAVONOIDS; HUMANS; MALE; MIDDLE AGED; OSTEOARTHRITIS, KNEE; PAIN; PAIN MEASUREMENT; PINUS; PLANT BARK; QUALITY OF LIFE; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

PINUS PINASTER;

EID: 50149110898     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.2461     Document Type: Article

References (18)

1. Ahmed S, Anuntiyo J, Malemud CJ et al. 2005. Biological basis for the use of botanicals in osteoarthritis and rheumatoid arthritis: a review. Evid Based Complement Alternat Med 2: 301-308.
2. Ahmed S, Wang N, Lalonde M et al. 2004. Green tea polyphenol epigallocatechin-3-gallate (EGCG) differentially inhibits interleukin-1β- induced expression of matrix metalloproteinase-1 and -13 in human chondrocytes. J Pharmacol Exp Ther 308: 767-773.
3. Bellamy N. 1995. WOMAC Osteoarthritis Index. A User's Guide, 2nd edn. Victoria Hospital: London, Ontario.
4. Cho KJ, Yun CH, Packer L et al. 2001. Inhibition mechanisms of bioflavonoids extracted from the bark of Pinus maritima on the expression of proinflammatory cytokines. Ann NY Acad Sci 928: 141-156.
5. Dixon T, Shaw M, Ebrahim S et al. 2004. Trends in hip and knee joint replacement: socioeconomic inequalities and projections of need. Ann Rheum Dis 63: 825-830.
6. Goldring MB. 1999. The role of cytokines as inflammatory mediators in osteoarthritis: lessons from animal models. Connect Tissue Res 40: 1-11.
7. Grimm T, Chovanová Z, Muchová J et al. 2006. Inhibition of NF-κB activation and MMP-9 secretion by plasma of human volunteers after ingestion of maritime pine bark extract (Pycnogenol). J Inflamm (Lond) 3: 1.
8. Grimm T, Schäfer A, Högger P. 2004. Antioxidant activity and inhibition of matrix metalloproteinases by metabolites of maritime pine bark extract (pycnogenol). Free Radic Biol Med 36: 811-822.
9. Hosseini S, Lee J, Sepulveda RT et al. 2001. A randomized, double blind, placebo controlled, prospective, 16 week crossover study to determine the role of Pycnogenol® in modifying blood pressure in mildly hypertensive patients. Nutr Res 21. 67-76.
10. Liao M-F, Yang H-M, Liao M-N et al. 2007. A randomized, double-blind, placebo-controlled trial on the effect of Pycnogenol on the climacteric syndrome in peri-menopausal women. Acta Obstet Gynecol Scand 86: 978-985.
11. Liu X, Wei J, Tan F et al. 2004. Pycnogenol, French maritime pine bark extract, improves endothelial function of hypertensive patients. Life Sci 74: 855-862.
12. Malemud CJ, Islam N, Haqqi TM. 2003. Pathophysiological mechanisms in osteoarthritis lead to novel therapeutic strategies. Cells Tissues Organs 174: 34-48.
13. Melzer D, Guralnik JM, Brock D. 2003. Prevalence and distribution of hip and knee joint replacements and hip implants in older Americans by the end of life. Aging Clin Exp Res 15: 60-66.
14. Peng J, Jones GL, Watson K. 2000. Stress proteins as biomarkers of oxidative stress: effects of antioxidant supplements. Free Radic Biol Med 28: 1598-1606.
15. Quam JP, Michet CJ Jr, Wilson MG et al. 1991. Total knee arthroplasty: a population-based study. Mayo Clin Proc 66: 589-595.
16. Rohdewald PJ. 2005. Pycnogenol®, French maritime pine bark extract. In Encyclopedia of Dietary Supplements, Coates PM, Blackman MR, Cragg G, Levine M, Moss J, White J (eds). Marcel Dekker: New York, 545-553.
17. Saliou C, Valacchi G, Rimbach G. 2001. Assessing bioflavonoids as regulators of NF-κB activity and inflammatory gene expression in mammalian cells. Methods Enzymol 335: 380-387.
18. Schäfer A, Chovanová Z, Muchová J et al. 2006. Inhibition of COX-1 and COX-2 activity by plasma of human volunteers after ingestion of French maritime pine bark extract (Pycnogenol). Biomed Pharmacother 60: 5-9.